Filter
256
Text search:
drug
dosing
Featured
Recommendations
35
New Publications
55
Language
Document type
No document type
136
Guidelines
58
Studies & Reports
30
Training Material
10
Manuals
6
Strategic & Response Plan
5
Fact sheets
4
Situation Updates
2
Resource Platforms
2
App
1
Infographics
1
Online Courses
1
Countries / Regions
India
12
South Africa
12
Kenya
9
Rwanda
9
Global
8
Tanzania
7
Ethiopia
6
Nigeria
5
Ghana
4
Uganda
4
Bangladesh
4
Western and Central Europe
4
Africa
4
USA
3
Sierra Leone
2
Zimbabwe
2
Philippines
2
South Sudan
2
Zambia
2
Syria
2
Cambodia
2
Malawi
2
Lesotho
2
Liberia
1
Congo, Democratic Republic of
1
Cameroon
1
Haiti
1
Nepal
1
Iraq
1
Germany
1
Sudan
1
Namibia
1
Ukraine
1
Myanmar / Burma
1
West and Central Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Tajikistan
1
Russia
1
Georgia
1
Authors & Publishers
Publication Years
Category
Countries
75
Clinical Guidelines
51
Women & Child Health
15
Capacity Building
11
Public Health
9
Key Resources
2
Annual Report MEDBOX
1
Pharmacy & Technologies
1
Toolboxes
HIV
38
TB
32
AMR
18
Pharmacy
16
Mental Health
11
NTDs
11
COVID-19
9
NCDs
9
Ebola & Marburg
5
Caregiver
5
Conflict
3
Refugee
3
Malaria
3
Polio
2
Specific Hazards
2
Cholera
1
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
Guidelines for the Prevention and Containment of Antimicrobial Resistance in South African Hospitals
These guidelines form part of efforts to institutionalise the prevention and containment of antimicrobial resistance (AMR) in health care facilities in South Africa, as outlined in the Antimicrobial Resistance Strategic Framework and Implementation Plan. The focus of these guidelines is on two inte
...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform
...
PARTICIPANT GUIDE.
This Participant Guide has been designed to assist health facilities and community based non-clinicians to develop skills to provide linkage to care, adherence and retention in care services for chronic conditions
Case Manangement Training Modules
This updated glossary for malaria aims to improve communication and mutual understanding within the scientific community, as well as with funding agencies, public health officials responsible for malaria programmes, and policy-makers in malaria-endemic countries
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems and design interventions to improve access to and use of medicines for children. It is a resource for
...
Schizophr Bull. 2014 Jan;40(1):192-213. doi: 10.1093/schbul/sbs150. Epub 2012 Dec 17.
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t
...
Examining the infrastructure of the Russian and USA healthcare systems with respect to the management of HIV patients
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
Human African trypanosomiasis (HAT), or sleeping sickness, is an endemic disease in 36 sub-Saharan African countries, typically occurring in underdeveloped areas, where
health systems face significant difficulties of diverse natures.
The target audience for this guideline is primarily for health care providers nurses, doctors, social workers and other people involved in HIV response in Rwanda so that they are capable of offering quality care services to patients over a long time. The new National Guidelines for Prevention and Ma
...
SECOND MEETING REPORT
DECATUR, GA, USA, 26 JUNE 2016
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to
...
